MOAB Ch14.18

{
  "id": "MLC-T-ONC-005445",
  "term": "MOAB Ch14.18",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (IL-2), and 13-cis-retinoic acid to treat children with high-risk neuroblastoma. It is used in patients whose disease has gotten better with other anticancer treatment. MOAB Ch14.18 binds to a substance called GD2, which is found on some types of cancer cells. MOAB Ch14.18 may block GD2 and help the immune system kill cancer cells. It is a type of monoclonal antibody. Also called Ch14.18, dinutuximab, monoclonal antibody Ch14.18, and Unituxin.",
  "synonyms": [
    "Ch14.18",
    "dinutuximab",
    "monoclonal antibody Ch14.18",
    "Unituxin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/moab-ch14-18/"
}